Ratings On Mozambique Affirmed At 'B+/B' On Continued Growth And Donor Support; Outlook Stable Dec 11

  • ID: 2030767
  • December 2011
  • Region: Mozambique
  • Standard & Poors
1 of 3


  • Mozambique (Republic of)
  • MORE

The Republic of Mozambique benefits from a track record of good macroeconomic management, favorable growth prospects, a rapidly growing mining sector, and very strong donor support. The rating is constrained by the country's very low GDP per capita (even when compared to peers) as well as a history of price-rise-related social unrest and significant development challenges. We are affirming the 'B+/B' foreign- and local-currency sovereign credit ratings on the Republic of Mozambique. The stable outlook balances our view that we expect donor support will continue to support fiscal and external performance, strong growth will continue, and that the political situation will remain broadly stable. LONDON (Standard & Poor's) Dec. 9, 2011--Standard & Poor's Ratings Services today affirmed its 'B+' long-term...

Companies mentioned in this report are:
- Mozambique (Republic of)

Action: Affirmed
Action: Outlook: Stable

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Mozambique (Republic of)

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.